← Open Payments lookup

SIMANGELE TSHUMA: Open Payments

NPI 1285251041 · BURLESON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,626 in 38 payments from 17 companies in 2025. Trend: 2023 $2,745 · 2024 $2,158 · 2025 $1,626

Long term medical supply or device loan: $1,000Food & beverage: $626
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation13$1,037
Regeneron Healthcare Solutions, Inc.3$87
Eisai Inc.3$74
Incyte Corporation3$72
Merck Sharp & Dohme LLC2$58
SUN PHARMACEUTICAL INDUSTRIES INC.2$46
AstraZeneca Pharmaceuticals LP2$39
ARRAY BIOPHARMA INC1$29
Aveo Pharmaceuticals, Inc.1$25
Blue Earth Diagnostics1$23

Products named: KISQALI, Lenvima, KEYTRUDA, LYNOZYFIC, MONJUVI, Odomzo, LIBTAYO, XALKORI.

Industry payments across TX — which companies pay providers there.